We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
-4.03%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
10 Year Est. Return
AUM
$313M
AUM Growth
-$123M
Cap. Flow
-$105M
Cap. Flow %
-33.38%
Top 10 Hldgs %
5.62%
Holding
1,231
New
357
Increased
143
Reduced
217
Closed
514

Top Buys

Rank Stock Value
1
HAS icon
Hasbro
HAS
+$2.15M
2
AMAT icon
Applied Materials
AMAT
+$2.12M
3
EOG icon
EOG Resources
EOG
+$1.77M
4
IT icon
Gartner
IT
+$1.72M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.68M

Top Sells

Rank Stock Value
1
P
Everpure Inc
P
+$2.28M
2
GAP
The Gap Inc
GAP
+$2.19M
3
AVAV icon
AeroVironment
AVAV
+$1.9M
4
PD icon
PagerDuty
PD
+$1.88M
5
DVN icon
Devon Energy
DVN
+$1.85M

Sector Composition

Rank Sector Weight
1 Technology 22.64%
2 Industrials 13.86%
3 Healthcare 13.45%
4 Consumer Discretionary 13.29%
5 Utilities 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRO icon
701
Sutro Biopharma
STRO
$423M
$61.9K 0.02%
3,364
-9,521
-74% -$291K
HPP
702
Hudson Pacific Properties
HPP
$740M
$61.4K 0.02%
2,893
-1,715
-37% -$46.9K
OABI icon
703
OmniAb
OABI
$491M
$61K 0.02%
17,226
+6,001
+53% +$23.7K
VSTM icon
704
Verastem
VSTM
$615M
$60.7K 0.02%
+11,741
New +$46.2K
PRME icon
705
Prime Medicine
PRME
$571M
$59.7K 0.02%
+20,441
New +$71.8K
UPLD icon
706
Upland Software
UPLD
$14.5M
$58.5K 0.02%
+1,348
New +$43.7K
SRG
707
Seritage Growth Properties
SRG
$136M
$56.6K 0.02%
13,743
-22,182
-62% -$95.5K
TRUE
708
DELISTED
TrueCar
TRUE
$51.1K 0.02%
13,713
-9,425
-41% -$37K
SRTA
709
Strata Critical Medical Inc
SRTA
$525M
$51K 0.02%
12,008
-98,422
-89% -$375K
BORR
710
Borr Drilling
BORR
$1.28B
$48.1K 0.02%
12,323
-10,374
-46% -$44.3K
BHR
711
Braemar Hotels & Resorts
BHR
$139M
$47.7K 0.02%
+15,898
New +$51.5K
AMPS
712
DELISTED
Altus Power
AMPS
$46.4K 0.01%
11,407
-114,486
-91% -$419K
AMBP icon
713
Ardagh Metal Packaging
AMBP
$2.97B
$41.9K 0.01%
13,905
-17,956
-56% -$64.7K
TNGX icon
714
Tango Therapeutics
TNGX
$4.51B
$38K 0.01%
+12,307
New +$57.1K
PDSB icon
715
PDS Biotechnology
PDSB
$40.9M
$22.9K 0.01%
14,026
-26,156
-65% -$69.2K
ALEC icon
716
Alector
ALEC
$189M
$19.6K 0.01%
+10,383
New +$39.1K
EDIT icon
717
Editas Medicine
EDIT
$432M
$19.1K 0.01%
15,024
-62,639
-81% -$160K
ABNB icon
718
Airbnb
ABNB
$111B
-4,130
Closed -$524K
ABSI icon
719
Absci
ABSI
$1.53B
-79,178
Closed -$302K
ABT icon
720
Abbott
ABT
$188B
-3,316
Closed -$378K
ABUS icon
721
Arbutus Biopharma
ABUS
$907M
-67,455
Closed -$260K
ACCO icon
722
Acco Brands
ACCO
$402M
-23,712
Closed -$130K
ACI icon
723
Albertsons Companies
ACI
$5.89B
-27,964
Closed -$517K
ACTG icon
724
Acacia Research
ACTG
$465M
-27,187
Closed -$127K
ADSK icon
725
Autodesk
ADSK
$54.1B
-2,591
Closed -$714K

Similar funds

Sherbrooke Park Advisers's Q4 2024 Portfolio in Review

As of Q4 2024, Sherbrooke Park Advisers held 1,231 positions worth $313M, down 28% from $436M the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

Sherbrooke Park Advisers withdrew a net $105M in Q4 2024, closing 514 positions and reducing 217 holdings. Its most notable exit was Everpure Inc, an estimated $2.28M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Sherbrooke Park Advisers opened a new position in Applied Materials worth $1.9M.

  • Sherbrooke Park Advisers's largest Q4 2024 buy was Applied Materials: 11,677 shares worth $1.9M.
  • Sherbrooke Park Advisers added most to Hasbro in Q4 2024, an estimated $2.15M increase.
  • Sherbrooke Park Advisers's biggest Q4 2024 reduction was The Gap Inc, cutting an estimated $2.19M.
  • Sherbrooke Park Advisers fully exited Everpure Inc in Q4 2024, selling an estimated $2.28M.
  • Sherbrooke Park Advisers's ten largest holdings make up 5.6% of its $313M portfolio in Q4 2024.
  • Sherbrooke Park Advisers opened 357 new positions and closed 514 in Q4 2024.
  • Sherbrooke Park Advisers's portfolio value fell 28% quarter-over-quarter to $313M.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.